Early treatment, DMARDs tied to rheumatoid arthritis remission

06/4/2013 | DailyRx.com

Patients with early rheumatoid arthritis who began treatment within the first 12 weeks of symptom onset were two times more likely to achieve remission than those who started treatment later, a study involving 1,795 patients found. The odds of achieving remission were 1.65 times higher in patients treated with disease-modifying antirheumatic drugs within the first three months of onset compared with those who started DMARD therapy later. The study was published in Annals of the Rheumatic Diseases.

View Full Article in:

DailyRx.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC